Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$41.09 USD
+0.84 (2.09%)
Updated May 31, 2024 03:59 PM ET
After-Market: $41.13 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Brokerage Reports
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 381 - 400 ( 441 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
New Products Did Well, Revenue Declines Easing
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of January 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Third Quarter Results Depressed by Loss of Plavix Sales
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
HCV Update: Vertex Reports Impressive Phase 1 Nuc Data; Seeking DAA(s) for Combination in Phase 2; Read-through for ACHN and IDIX
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Plavix Patent Expiration Impacted Second Quarter Results
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company to Acquire Amylin Pharmaceuticals, Expand Partnership with AstraZeneca
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S